A Paralysis Prescription

A Paralysis Prescription

I review pretty much everything related to AI governance. It’s central to my work at Stanford. It’s also central to what I call the “AI Life Cycle Core Principles” framework, which is now almost three years in the making. But governance, which, at a high level, stands for the sum of the organization’s policies, procedures, processes, and practices relative to AI, didn’t start as a central principle. It was just one of 37 principles that coalesced over time into what it takes to properly and efficiently deal with AI. But Governance (AILCCP principles appear in uppercase) rather quickly claimed its prominence. The more work I did on the framework, the more I saw that without proper alignment with the Governance principle the organization’s prospects of successful AI implementation are bleak. Now, it’s the single most important principle.

And this brings me to the present issue. Without naming names (I have no interest in stirring discomfort) I want to shed light on a common practice among consultants when it comes to talking about AI governance. (And yes, I am using the term in lowercase on purpose.) 

I recently came across a white paper published by what I’ll call the “Acme Group.” The paper is actually quite similar to many others you will find out there. So, my comments here should be helpful beyond just this example. And what you will see fairly quickly is that the advice, as well-intentioned as it may be, is a prescription for paralysis.

Acme Group seeks to advance its AI consulting expertise. It prescribes at least seven distinct committee or oversight structures:

  1. Generative AI Governance Committee (cross-functional)
  2. Ethics Committee or Advisory Board
  3. Technology Assessment processes
  4. Post-Implementation Review bodies
  5. Reputation Response Team
  6. Innovation Labs Oversight
  7. Various “cross-functional teams” for specific controls

Each of these bodies requires membership, meeting cadences, documentation, and presumably the authority to delay or block AI implementation initiatives. The cumulative effect is decision diffusion: accountability is dispersed across so many nodes that no single entity possesses the authority or incentive to say “yes.”

Three Dimensions of the Critique

1. Velocity Degradation

Every committee represents a synchronization point. If a GenAI initiative must secure approval from governance, ethics, technology assessment, and post-implementation review bodies (each meeting monthly or quarterly), the calendar arithmetic alone suggests multi-month latency for even modest deployments.

Acme Group advises securing stakeholder approval before deployment. Sounds reasonable, or at the very least, harmless, right? It’s not. When multiplied across committees, this requirement becomes a veto chain where any single objection halts progress. Too many parties holding blocking rights inevitably results in underutilization of the resource (in this case, the desired AI capability).

2. Accountability Diffusion

The proliferation of oversight bodies paradoxically undermines the very accountability the framework purports to establish. When seven committees review a decision, who bears responsibility for its consequences? The AILCCP principle of Accountability requires, among other things, that “output is traceable to appropriate responsible party.” Yet the Acme Group structure distributes decision rights so broadly that traceability becomes an exercise in finger-pointing.

When responsibility is shared, individual ownership diminishes. Committee members assume others have conducted rigorous review, resulting in superficial approval from all quarters and genuine scrutiny from none.

3. Performative Governance

Perhaps the most pointed critique: such committee structures can become governance theater. Organizations form committees to their heart’s content, draft policies, and create gigabytes of documentation. Window dressing. The appearance of oversight; zero substance.

This misguided approach generates an organization that is optimized for demonstrating diligence rather than exercising judgment. It’s a prescription for paralysis.

Aligning with the Governance Principle

The Governance principle does not dismiss the importance of forming committees, drafting policies, and creating documentation to promote deliberation. An organization that aligns with this principle will find that it calls for properly calibrating effort to the context of its operations; it’s not one-size-fits-all. An organization operating in healthcare or financial services might very well benefit from regimes that intentionally introduce friction. But the emphasis here is that this must be the product of thoughtful intentionality. The decision to create this type of structure renders deliberation a feature, not a bug.